Evidence-based obstetric ethics and informed decision-making by pregnant women about invasive diagnosis after first-trimester assessment of risk for trisomy 21

This publication has 15 references indexed in Scilit:

• Prospective first-trimester screening for trisomy 21 in 30,564 pregnancies
  American Journal of Obstetrics and Gynecology, 2005
• Multicenter study of first‐trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk‐orientated two‐stage first‐trimester screening
  Ultrasound in Obstetrics & Gynecology, 2005
• Is nuchal translucency screening associated with different rates of invasive testing in an older obstetric population?
  American Journal of Obstetrics and Gynecology, 2004
• Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one‐stop clinic: a review of three years prospective experience
  BJOG: An International Journal of Obstetrics and Gynaecology, 2003
• One‐stop clinic for assessment of risk for trisomy 21 at 11–14 weeks: a prospective study of 15 030 pregnancies
  Ultrasound in Obstetrics & Gynecology, 2002
• A screening program for trisomy 21 at 10–14 weeks using fetal nuchal translucency, maternal serum free β‐human chorionic gonadotropin and pregnancy‐associated plasma protein‐A
  Ultrasound in Obstetrics & Gynecology, 1999
• Screening for fetal chromosomal abnormalities: need to change the rules
  Ultrasound in Obstetrics & Gynecology, 1994
• Users' Guides to the Medical Literature
  JAMA, 1993
• Randomised comparison of amniocentesis and transabdominal and transcervical chorionic villus sampling
  The Lancet, 1992
• RANDOMISED CONTROLLED TRIAL OF GENETIC AMNIOCENTESIS IN 4606 LOW-RISK WOMEN
  Published by Elsevier ,1986